Suppr超能文献

肝移植期间计划性体外生命支持的应用:体外膜肺氧合(ECMO)和连续性肾脏替代治疗(CRRT)作为预防性治疗的潜力——病例报告与文献综述

Planned Extracorporeal Life Support Employment during Liver Transplantation: The Potential of ECMO and CRRT as Preventive Therapies-Case Reports and Literature Review.

作者信息

Laici Cristiana, Bianchini Amedeo, Miglionico Noemi, Bambagiotti Niccolò, Vitale Giovanni, Fallani Guido, Ravaioli Matteo, Siniscalchi Antonio

机构信息

Postoperative and Abdominal Organ Transplant Intensive Care Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy.

出版信息

J Clin Med. 2023 Feb 3;12(3):1239. doi: 10.3390/jcm12031239.

Abstract

Liver Transplantation (LT) has become the gold standard treatment for End-Stage Liver Disease (ESLD). One of the main strategies to manage life-threatening complications, such as cardio-respiratory failure, is Extracorporeal Membrane Oxygenation (ECMO) in the peri-transplantation period, with different configurations of the technique and in combination with other extracorporeal care devices such as Continuous Renal Replacement Therapy (CRRT). This retrospective study includes three clinical cases of planned ECMO support strategies in LT and evaluates their application compared with current literature exploring PubMed/Medline. The three LT supported with ECMO and CRRT were performed at IRCCS Polyclinic S. Orsola-Malpighi, Bologna. All three cases of patients with compromised organ function analysed produced positive outcomes. The planned use of ECMO and CRRT support in peri-transplantation has allowed the patients to overcome contraindications and successfully undergo LT. In recent years, only a few reports have documented successful LT outcomes performed with intraoperative ECMO in critically ESLD patients. However, the management of LT with ECMO and/or CRRT assistance is an emerging challenge, with the need for more published evidence on this topic to guide treatment choices in patients with severe, acute and reversible respiratory and cardiovascular failure after LT.

摘要

肝移植(LT)已成为终末期肝病(ESLD)的金标准治疗方法。处理危及生命的并发症(如心肺衰竭)的主要策略之一是在移植围手术期采用体外膜肺氧合(ECMO),该技术有不同的配置,并可与其他体外支持设备(如连续性肾脏替代治疗(CRRT))联合使用。这项回顾性研究纳入了三例肝移植中计划性ECMO支持策略的临床病例,并与检索PubMed/Medline的现有文献相比,评估了这些策略的应用情况。三例接受ECMO和CRRT支持的肝移植手术在博洛尼亚的圣奥索拉-马尔皮基综合医院(IRCCS)进行。分析的所有三例器官功能受损患者均取得了积极的结果。移植围手术期计划性使用ECMO和CRRT支持使患者克服了禁忌证并成功接受了肝移植。近年来,仅有少数报告记录了在严重ESLD患者中术中使用ECMO进行肝移植取得成功的结果。然而,在ECMO和/或CRRT辅助下进行肝移植的管理是一个新出现的挑战,需要更多关于该主题的已发表证据来指导肝移植后出现严重、急性和可逆性呼吸及心血管衰竭患者的治疗选择。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6c35/9953574/af73c13365fc/jcm-12-01239-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验